Tertomotide Not Yet Recruiting Phase 3 Trials for Moderate to Severe Alzheimer's Disease Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT05303701GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD)